Concepedia

Publication | Closed Access

Proteasome Inhibitor-Based Primary Therapy for Antibody-Mediated Renal Allograft Rejection

184

Citations

12

References

2010

Year

Abstract

Proteasome inhibitor-based combination therapy provides a potential means for rapid DSA elimination in early acute AMR in renal transplant recipients.

References

YearCitations

Page 1